15
Participants
Start Date
June 15, 2023
Primary Completion Date
September 22, 2023
Study Completion Date
Venetoclax
Oral; Tablet
Acpru /Id# 255783, Grayslake
Lead Sponsor
AbbVie
INDUSTRY